Novanta to Present at 19th Annual Needham Growth Investor Conference on January 12, 2017

BEDFORD, Mass., Dec. 22, 2016 /PRNewswire/ -- Novanta Inc. (NASDAQ: NOVT), a global leader and supplier of photonics, precision motion, and vision technologies to original equipment manufacturers in the medical and advanced manufacturing technology markets, will present at the 19^th Annual Needham Growth Conference in New York City. The Company's presentation will be on Thursday, January 12, 2017.

Matthijs Glastra, Novanta's chief executive officer, and Robert Buckley, Novanta's chief financial officer, will attend the conference.    

A copy of the presentation to be presented will be available on the Investor Relations section of the Company's website at www.novanta.com.      

About Novanta

Novanta is a leading global supplier of core technology solutions that give advanced manufacturing and healthcare OEMs a competitive advantage. We combine deep expertise at the intersection of photonics and motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers' demanding applications. We deliver highly engineered photonics, vision and precision motion solutions to customers around the world. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta's common shares are quoted on NASDAQ under the ticker symbol "NOVT".

More information about Novanta is available on the Company's website at www.novanta.com.  For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com.

Novanta Inc.
Investor Relations Contact:
Robert J. Buckley
(781) 266-5137

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/novanta-to-present-at-19th-annual-needham-growth-investor-conference-on-january-12-2017-300382808.html

SOURCE Novanta Inc.